178 related articles for article (PubMed ID: 1326813)
1. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine.
Konishi E; Pincus S; Paoletti E; Laegreid WW; Shope RE; Mason PW
Virology; 1992 Sep; 190(1):454-8. PubMed ID: 1326813
[TBL] [Abstract][Full Text] [Related]
2. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
Pugachev KV; Mason PW; Shope RE; Frey TK
Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
[TBL] [Abstract][Full Text] [Related]
3. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
4. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus.
Konishi E; Pincus S; Fonseca BA; Shope RE; Paoletti E; Mason PW
Virology; 1991 Nov; 185(1):401-10. PubMed ID: 1833876
[TBL] [Abstract][Full Text] [Related]
5. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E
Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826
[TBL] [Abstract][Full Text] [Related]
6. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a recombinant MVA and a DNA vaccine for Japanese encephalitis virus in swine.
Nam JH; Cha SL; Cho HW
Microbiol Immunol; 2002; 46(1):23-8. PubMed ID: 11911185
[TBL] [Abstract][Full Text] [Related]
8. Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine.
McCown J; Cochran M; Putnak R; Feighny R; Burrous J; Henchal E; Hoke C
Am J Trop Med Hyg; 1990 May; 42(5):491-9. PubMed ID: 2160199
[TBL] [Abstract][Full Text] [Related]
9. Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys.
Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
Am J Trop Med Hyg; 1999 Mar; 60(3):343-9. PubMed ID: 10466959
[TBL] [Abstract][Full Text] [Related]
10. Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes.
Nam JH; Wyatt LS; Chae SL; Cho HW; Park YK; Moss B
Vaccine; 1999 Jan; 17(3):261-8. PubMed ID: 9987162
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.
Kanesa-thasan N; Smucny JJ; Hoke CH; Marks DH; Konishi E; Kurane I; Tang DB; Vaughn DW; Mason PW; Shope RE
Vaccine; 2000 Oct; 19(4-5):483-91. PubMed ID: 11027812
[TBL] [Abstract][Full Text] [Related]
12. Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates.
Konishi E; Kurane I; Mason PW; Shope RE; Kanesa-Thasan N; Smucny JJ; Hoke CH; Ennis FA
Vaccine; 1998 May; 16(8):842-9. PubMed ID: 9627942
[TBL] [Abstract][Full Text] [Related]
13. The C Terminus of the Core β-Ladder Domain in Japanese Encephalitis Virus Nonstructural Protein 1 Is Flexible for Accommodation of Heterologous Epitope Fusion.
Yen LC; Liao JT; Lee HJ; Chou WY; Chen CW; Lin YL; Liao CL
J Virol; 2016 Feb; 90(3):1178-89. PubMed ID: 26559836
[TBL] [Abstract][Full Text] [Related]
14. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.
Yasuda A; Kimura-Kuroda J; Ogimoto M; Miyamoto M; Sata T; Sato T; Takamura C; Kurata T; Kojima A; Yasui K
J Virol; 1990 Jun; 64(6):2788-95. PubMed ID: 2159544
[TBL] [Abstract][Full Text] [Related]
15. Construction and Immunogenicity of Recombinant Vaccinia Virus Vaccine Against Japanese Encephalitis and Chikungunya Viruses Infection in Mice.
Zhang Y; Han JC; Jing J; Liu H; Zhang H; Li ZH; Jin NY; Lu HJ
Vector Borne Zoonotic Dis; 2020 Oct; 20(10):788-796. PubMed ID: 32584657
[TBL] [Abstract][Full Text] [Related]
16. Antibodies generated by immunization with the NS1 protein of West Nile virus confer partial protection against lethal Japanese encephalitis virus challenge.
Sun E; Zhao J; TaoYang ; Xu Q; Qin Y; Wang W; Wei P; Wu D
Vet Microbiol; 2013 Sep; 166(1-2):145-53. PubMed ID: 23834965
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC.
Tartaglia J; Cox WI; Pincus S; Paoletti E
Dev Biol Stand; 1994; 82():125-9. PubMed ID: 7958466
[TBL] [Abstract][Full Text] [Related]
18. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X
Virol J; 2015 Dec; 12():214. PubMed ID: 26651827
[TBL] [Abstract][Full Text] [Related]
19. A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in Pigs.
García-Nicolás O; Ricklin ME; Liniger M; Vielle NJ; Python S; Souque P; Charneau P; Summerfield A
Viruses; 2017 May; 9(5):. PubMed ID: 28531165
[TBL] [Abstract][Full Text] [Related]
20. Protection of pigs against mosquito-borne Japanese encephalitis virus by immunization with a live attenuated vaccine.
Sasaki O; Karoji Y; Kuroda A; Karaki T; Takenokuma K; Maeda O
Antiviral Res; 1982 Dec; 2(6):355-60. PubMed ID: 6131643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
